- 讲师介绍
- 视频介绍
讲师介绍
Dr. Elizabeth Gillie
Dr. Elizabeth Gillies is well-versed in using CRISPR/Cas9 genome-editing technology for creating cell-based models with disease-relevant mutations.
视频介绍
<form action="./Webinars.aspx?currentfilters=357e249267a94bb698cfd80d5890a59b&Page=1" id="mainform" method="post">
<main id="main" role="main">
了解CRISPR/CSa9这项先进技术是如何被用来引入一个特定的点突变,使375A黑色素瘤获得耐药性。这种等基因细胞系对MEK和BRAF抑制剂都具有耐药性,并且对针对Ras/Raf MAPK信号通路上游和下游元件的联合疗法敏感。
</main> </form>